PL355097A1 - Biphenyl derivatives used as nhe-3 inhibitors - Google Patents
Biphenyl derivatives used as nhe-3 inhibitorsInfo
- Publication number
- PL355097A1 PL355097A1 PL00355097A PL35509700A PL355097A1 PL 355097 A1 PL355097 A1 PL 355097A1 PL 00355097 A PL00355097 A PL 00355097A PL 35509700 A PL35509700 A PL 35509700A PL 355097 A1 PL355097 A1 PL 355097A1
- Authority
- PL
- Poland
- Prior art keywords
- nhe
- inhibitors
- derivatives used
- biphenyl derivatives
- biphenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19945302A DE19945302A1 (de) | 1999-09-22 | 1999-09-22 | Biphenylderivate als NHE-3-Inhibitoren |
Publications (1)
Publication Number | Publication Date |
---|---|
PL355097A1 true PL355097A1 (en) | 2004-03-22 |
Family
ID=7922831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL00355097A PL355097A1 (en) | 1999-09-22 | 2000-09-04 | Biphenyl derivatives used as nhe-3 inhibitors |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1214291A1 (zh) |
JP (1) | JP2004500338A (zh) |
KR (1) | KR20020033818A (zh) |
CN (1) | CN1555356A (zh) |
AU (1) | AU7649700A (zh) |
BR (1) | BR0014199A (zh) |
CA (1) | CA2387529A1 (zh) |
CZ (1) | CZ2002815A3 (zh) |
DE (1) | DE19945302A1 (zh) |
HU (1) | HUP0202891A3 (zh) |
MX (1) | MXPA02003087A (zh) |
NO (1) | NO20021407D0 (zh) |
PL (1) | PL355097A1 (zh) |
SK (1) | SK3342002A3 (zh) |
WO (1) | WO2001021582A1 (zh) |
ZA (1) | ZA200203095B (zh) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10163239A1 (de) * | 2001-12-21 | 2003-07-10 | Aventis Pharma Gmbh | Substituierte Imidazolidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie enthaltendes Medikament |
US7049333B2 (en) | 2002-06-04 | 2006-05-23 | Sanofi-Aventis Deutschland Gmbh | Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
US20050054705A1 (en) | 2003-02-04 | 2005-03-10 | Aventis Pharma Deutschland Gmbh | N-substituted (benzoimidazol-2-yl) phenylamines, process for their preparation, their use as medicament or diagnostic aid, and medicament comprising them |
DE10304374A1 (de) | 2003-02-04 | 2004-08-05 | Aventis Pharma Deutschland Gmbh | Neue substituierte 2-Aminoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE10341240A1 (de) | 2003-09-08 | 2005-04-07 | Aventis Pharma Deutschland Gmbh | Substituierte Thienoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
US7534894B2 (en) | 2003-09-25 | 2009-05-19 | Wyeth | Biphenyloxy-acids |
DE102005001411A1 (de) | 2005-01-12 | 2006-07-27 | Sanofi-Aventis Deutschland Gmbh | Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
JP2010531886A (ja) | 2007-06-28 | 2010-09-30 | サノフィ−アベンティス・ユー・エス・エルエルシー | ナトリウム/プロトン交換輸送体3型阻害剤として有用なベンゾイミダゾールチエニルアミン化合物及びその誘導体の製造方法 |
BRPI0918502A2 (pt) | 2008-09-02 | 2015-12-01 | Sanofi Aventis | aminoindanos substituídos e análogos dos mesmos, e o uso farmacêutico dos mesmos |
KR20200111230A (ko) | 2008-12-31 | 2020-09-28 | 알데릭스, 인코포레이티드 | 체액 저류 또는 염 과부하와 연관된 장애 및 위장관 장애의 치료 시에 nhe-매개된 역수송을 억제하는 화합물 및 방법 |
WO2018129556A1 (en) | 2017-01-09 | 2018-07-12 | Ardelyx, Inc. | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
ES2575478T3 (es) | 2011-03-15 | 2016-06-28 | Astellas Pharma Inc. | Compuesto de guanidina |
CN103012200B (zh) * | 2011-09-20 | 2014-12-17 | 北京大学 | 具有β-分泌酶抑制功能的化合物及其制备方法与应用 |
US10376481B2 (en) | 2012-08-21 | 2019-08-13 | Ardelyx, Inc. | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
EP2887964B1 (en) | 2012-08-21 | 2019-07-03 | Ardelyx, Inc. | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
PL2983667T3 (pl) | 2013-04-12 | 2019-10-31 | Ardelyx Inc | Związki wiążące nhe3 oraz sposoby inhibicji transportu fosforanów |
MX2017001117A (es) | 2014-07-25 | 2017-05-08 | Taisho Pharmaceuticals Co Ltd | Compuesto de feniltetrahidroisoquinolina sustituido con heteroarilo. |
JP2020505333A (ja) | 2017-01-09 | 2020-02-20 | アルデリックス, インコーポレイテッド | Nhe媒介性アンチポートの阻害薬 |
AU2018205400B2 (en) | 2017-01-09 | 2022-07-14 | Ardelyx, Inc. | Compounds useful for treating gastrointestinal tract disorders |
BR112020002322A2 (pt) | 2017-08-04 | 2020-09-01 | Ardelyx, Inc. | derivados de ácido glicirretinínico para o tratamento de hipercalemia |
CA3129233A1 (en) | 2019-02-07 | 2020-08-13 | Ardelyx, Inc. | Glycyrrhetinic acid derivatives for use in treating hyperkalemia |
WO2020237096A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Combination for lowering serum phosphate in a patient |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19548812A1 (de) * | 1995-12-27 | 1997-07-03 | Hoechst Ag | Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikaments zur Atemstimulation |
DE19622222A1 (de) * | 1996-06-03 | 1997-12-04 | Hoechst Ag | Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikament zur Normalisierung der Serumlipide |
DE19737224A1 (de) * | 1997-08-27 | 1999-03-18 | Hoechst Marion Roussel De Gmbh | Pharmazeutisches Kombinationspräparat aus einem Inhibitor des Natrium-Wasserstoff-Austauschers und einem Arzneimittel zur Behandlung von Herz-Kreislauferkrankungen |
DE19819548A1 (de) * | 1998-04-30 | 1999-11-04 | Merck Patent Gmbh | Biphenylderivate |
-
1999
- 1999-09-22 DE DE19945302A patent/DE19945302A1/de not_active Withdrawn
-
2000
- 2000-09-04 BR BR0014199-2A patent/BR0014199A/pt not_active IP Right Cessation
- 2000-09-04 MX MXPA02003087A patent/MXPA02003087A/es unknown
- 2000-09-04 JP JP2001524962A patent/JP2004500338A/ja active Pending
- 2000-09-04 SK SK334-2002A patent/SK3342002A3/sk not_active Application Discontinuation
- 2000-09-04 AU AU76497/00A patent/AU7649700A/en not_active Abandoned
- 2000-09-04 HU HU0202891A patent/HUP0202891A3/hu unknown
- 2000-09-04 CN CNA008131600A patent/CN1555356A/zh active Pending
- 2000-09-04 CZ CZ2002815A patent/CZ2002815A3/cs unknown
- 2000-09-04 KR KR1020027003735A patent/KR20020033818A/ko not_active Application Discontinuation
- 2000-09-04 PL PL00355097A patent/PL355097A1/xx unknown
- 2000-09-04 WO PCT/EP2000/008616 patent/WO2001021582A1/de not_active Application Discontinuation
- 2000-09-04 CA CA002387529A patent/CA2387529A1/en not_active Abandoned
- 2000-09-04 EP EP00965915A patent/EP1214291A1/de not_active Withdrawn
-
2002
- 2002-03-21 NO NO20021407A patent/NO20021407D0/no unknown
- 2002-04-18 ZA ZA200203095A patent/ZA200203095B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP1214291A1 (de) | 2002-06-19 |
CA2387529A1 (en) | 2001-03-29 |
DE19945302A1 (de) | 2001-03-29 |
BR0014199A (pt) | 2002-05-21 |
CN1555356A (zh) | 2004-12-15 |
HUP0202891A3 (en) | 2003-11-28 |
JP2004500338A (ja) | 2004-01-08 |
SK3342002A3 (en) | 2002-07-02 |
MXPA02003087A (es) | 2003-08-20 |
NO20021407L (no) | 2002-03-21 |
ZA200203095B (en) | 2003-09-23 |
CZ2002815A3 (cs) | 2002-08-14 |
WO2001021582A1 (de) | 2001-03-29 |
HUP0202891A2 (hu) | 2003-02-28 |
AU7649700A (en) | 2001-04-24 |
KR20020033818A (ko) | 2002-05-07 |
NO20021407D0 (no) | 2002-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL355097A1 (en) | Biphenyl derivatives used as nhe-3 inhibitors | |
SI1686119T1 (sl) | Derivati pirimidin-5-ona kot inhibitorji ldl-pla2 | |
HUP0202450A3 (en) | N-heterocyclic derivatives as nos inhibitors | |
GB9900416D0 (en) | Inhibitors | |
HUP0202713A3 (en) | Pteridinones as kinase inhibitors | |
PL356559A1 (en) | 2-guanidino-4-arylchinazolines as nhe-3 inhibitors | |
IL149034A0 (en) | Quinazoline derivatives as vegf inhibitors | |
HK1041407B (zh) | 作為環氧酶-2抑制劑的二芳基苯並吡喃衍生物 | |
AU6623201A (en) | Colchinol derivatives as angiogenesis inhibitors | |
IL153484A0 (en) | Colchinol derivatives as angiogenesis inhibitors | |
IL146288A0 (en) | Vla-4 inhibitor compounds | |
HK1040076A1 (zh) | 作為整聯蛋白抑制劑的喹嗪酮 | |
IL149097A0 (en) | 4-carboxyamino-2-ethyl-1,2,3,4-thetrahydroquinoline crystal as cetp inhibitor | |
AU6381701A (en) | Bisamidino compounds as nhe-3 inhibitors | |
GB9927315D0 (en) | Inhibitor compositions | |
PL345283A1 (en) | Biphenyl derivatives | |
HK1047276A1 (zh) | 作為pde4抑制劑的四氫噻喃2,3-二氮雜萘酮類衍生物 | |
HK1042695A1 (zh) | 蛋白酶抑制劑 | |
PL343598A1 (en) | Biphenyl derivatives | |
GB2389113B (en) | B-secretase inhibitor | |
HK1040510A1 (zh) | 氰聯苯衍化物 | |
PL347152A1 (en) | Benzamide derivatives as thrombin inhibitors | |
PL353054A1 (en) | Fluorene derivatives as integrin inhibitors | |
GB9929341D0 (en) | Inhibitors | |
GB9929340D0 (en) | Inhibitors |